Pulmatrix (PULM) Financials

$1.39

$0.03 (2.21%)

As on 04-Sep-2026 16:00EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	7.81	7.30	6.07	5.17
Cost of Revenue	0.04	0.04	7.17	15.52	1.55	15.38
Gross Profit	-0.04	-0.04	0.64	-8.22	6.07	-10.21
Operating Expenses	4.07	5.13	10.40	6.52	25.02	9.95
Operating Profit (EBIT)	-4.11	-5.17	-9.76	-14.74	-18.95	-20.17
Other Income	--	--	--	--	--	--
Profit before Tax	-4.01	-5.16	-9.56	-14.12	-18.84	-20.17
Provision for Tax	--	--	-9.56	1.31	-0.11	2.33
Profit after Tax (Net Income)	-4.01	-5.16	-9.56	-14.12	-18.73	-20.17
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-18.84	-23.37

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	2.56	3.81	8.95	18.00	31.11	47.45
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.07	12.05	4.82	6.93
Current Liabilities	0.69	0.33	0.93	3.91	5.02	4.44
Total Liabilities	3.94	4.14	9.94	33.96	40.95	58.82

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.01	0.01	0.02	13.12	2.81	4.04
Current Assets	3.24	4.13	9.92	20.84	38.15	54.78
Total Assets	6.49	4.14	9.94	33.96	40.95	58.82
Total Debt*	--	--	--	8.76	0.86	2.29
Net Current Assets	--	3.80	8.99	16.93	33.13	50.34

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.43	-10.72	-15.99	-19.36	-19.73
Cash Flow from Investing Activities	--	--	-0.40	-0.68	-0.09	-0.14
Cash from Financing Activities	--	--	--	0.05	1.23	43.48
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.10	-1.41	-2.62	-3.87	-5.15	-7.02
Cash EPS ($)	-1.10	-1.41	-2.50	-3.41	-4.72	-6.59
Adjusted Book Value ($)	0.44	1.04	2.45	4.93	8.55	16.52
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.49	-2.93	-4.38	-5.32	-6.87
Free Cash Flow per Share ($)	--	-1.49	-3.04	-4.56	-5.34	-6.92

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-80.93	-53.55	-48.10	-45.84	-54.06
ROE (%)	-126.06	-80.93	-70.96	-57.51	-47.67	-57.15
ROA (%)	-60.87	-73.31	-43.55	-37.70	-37.54	-41.60
EBIT Margin (%)	--	--	-91.53	-193.49	-312.09	-320.95
Net Margin (%)	--	--	-122.46	-193.49	-308.43	-390.23
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	0.07	0.20	0.17	-0.59
EBIT Growth (%)	--	--	49.40	25.47	-14.21	-68.22
Net Profit Growth (%)	49.39	46.00	32.31	24.59	7.17	-4.47
EPS Growth (%)	49.39	0.46	0.32	0.25	0.27	0.34
Book Value Growth (%)	-54.37	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.58	-2.67	-0.48	-0.75	-0.06
Price / Book Value	3.50	2.14	2.85	0.38	0.45	0.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.57	-0.79	-2.27	0.26	1.19	3.06
Close Price ($)	1.70	2.23	6.98	1.86	3.88	8.75
High Price ($)	7.00	10.40	8.44	4.49	9.20	60.80
Low Price ($)	1.16	2.15	1.55	1.64	3.17	8.00
Market Cap ($ Cr)	5.08	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	0.49	0.03	0.05
Short term debt to equity ratio	--	--	--	0.02	0.03	0.03
Current Ratio	4.70	12.55	10.68	5.33	7.60	12.33
Quick Ratio	4.70	--	--	5.43	7.57	12.33
Interest Coverage	--	--	--	--	-170.69	-4,147.50

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	12.72	21.38	1.30
Asset Turnover	--	--	0.36	0.19	0.12	0.11
Receivable days	--	--	21.71	55.70	41.06	5.33
Inventory Days	--	--	-18.86	-2.55	18.09	7.92
Payable days	--	5,195.20	69.42	36.52	239.60	20.06
Cash Conversion Cycle	--	--	-66.57	16.63	-180.45	-6.81

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.